Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adalimumab therapy for refractory uveitis: a pilot study.
Diaz-Llopis M, García-Delpech S, Salom D, Udaondo P, Hernández-Garfella M, Bosch-Morell F, Quijada A, Romero FJ. Diaz-Llopis M, et al. Among authors: salom d. J Ocul Pharmacol Ther. 2008 Jun;24(3):351-61. doi: 10.1089/jop.2007.0104. J Ocul Pharmacol Ther. 2008. PMID: 18476805 Clinical Trial.
High-dose infliximab prophylaxis in endotoxin-induced uveitis.
Diaz-Llopis M, García-Delpech S, Salom D, Udaondo P, Bosch-Morell F, Quijada A, Romero FJ, Amselem L. Diaz-Llopis M, et al. Among authors: salom d. J Ocul Pharmacol Ther. 2007 Aug;23(4):343-50. doi: 10.1089/jop.2006.0148. J Ocul Pharmacol Ther. 2007. PMID: 17803432
Short-term results of a single intravitreal bevacizumab (avastin) injection versus a single intravitreal triamcinolone acetonide (kenacort) injection for the management of refractory noninfectious uveitic cystoid macular edema.
Lasave AF, Zeballos DG, El-Haig WM, Díaz-Llopis M, Salom D, Arevalo JF. Lasave AF, et al. Among authors: salom d. Ocul Immunol Inflamm. 2009 Nov-Dec;17(6):423-30. doi: 10.3109/09273940903221610. Ocul Immunol Inflamm. 2009. PMID: 20001264
108 results